These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 15936449

  • 1. Uniocular drug trial.
    Jones R, Triana MI, Zaslow K, Sponsel WE.
    Ophthalmology; 2005 Jun; 112(6):1170; author reply 1170-1. PubMed ID: 15936449
    [No Abstract] [Full Text] [Related]

  • 2. Uniocular drug trials.
    Rotchford AP, King AJ.
    Ophthalmology; 2004 Dec; 111(12):2315; author reply 2315-6. PubMed ID: 15582097
    [No Abstract] [Full Text] [Related]

  • 3. The uniocular drug trial and second-eye response to glaucoma medications.
    Realini T, Fechtner RD, Atreides SP, Gollance S.
    Ophthalmology; 2004 Mar; 111(3):421-6. PubMed ID: 15019313
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study.
    Shimmyo M.
    Am J Ophthalmol; 2005 Jun; 139(6):1148; author reply 1148-9. PubMed ID: 15953471
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Assessing the effectiveness of intraocular pressure-lowering therapy.
    Realini T.
    Ophthalmology; 2010 Nov; 117(11):2045-6. PubMed ID: 20970009
    [No Abstract] [Full Text] [Related]

  • 9. Modern alchemy: fixed combinations of glaucoma drugs.
    Katz LJ.
    Am J Ophthalmol; 2005 Jul; 140(1):125-6. PubMed ID: 16038653
    [No Abstract] [Full Text] [Related]

  • 10. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Franks WA, Renard JP, Cunliffe IA, Rojanapongpun P.
    Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
    Orzalesi N, Rossetti L, Bottoli A, Fogagnolo P.
    Ophthalmology; 2006 Feb; 113(2):239-46. PubMed ID: 16458092
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost.
    Miura K, Ito K, Okawa C, Sugimoto K, Matsunaga K, Uji Y.
    J Glaucoma; 2008 Feb; 17(3):233-7. PubMed ID: 18414111
    [Abstract] [Full Text] [Related]

  • 15. [When and how we start the treatment in patients with ocular hypertension or in glaucoma suspects?].
    Stefan C, Ene L, Coravu CO.
    Oftalmologia; 2014 Feb; 58(1):15-7. PubMed ID: 25145118
    [Abstract] [Full Text] [Related]

  • 16. Dorzolamide/timolol fixed combination versus latanoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
    Cvenkel B, Stewart JA, Nelson LA, Stewart WC.
    Curr Eye Res; 2008 Feb; 33(2):163-8. PubMed ID: 18293187
    [Abstract] [Full Text] [Related]

  • 17. Commercially available prostaglandin analogs for the reduction of intraocular pressure: similarities and differences.
    Bean GW, Camras CB.
    Surv Ophthalmol; 2008 Nov; 53 Suppl1():S69-84. PubMed ID: 19038626
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.